| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/J.GASTRO.2005.07.059 |
| P698 | PubMed publication ID | 16230069 |
| P2093 | author name string | Uri Ladabaum | |
| Kenneth Song | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer screening | Q19391980 |
| colorectal carcinoma | Q25493920 | ||
| colorectal cancer | Q188874 | ||
| P304 | page(s) | 1151-1162 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. | |
| P478 | volume | 129 |
| Q36552245 | A cost analysis of colonoscopy using microcosting and time-and-motion techniques |
| Q46251243 | A risk profile for advanced proximal neoplasms on diagnostic colonoscopy |
| Q36545130 | ACG colorectal cancer prevention action plan: update on CT-colonography |
| Q33858614 | Advantages of the AMDL-ELISA DR-70 (FDP) assay over carcinoembryonic antigen (CEA) for monitoring colorectal cancer patients |
| Q36942597 | Analysis of PTEN expression in large intestine polyps and its relation to the recognized histopathological and clinical risk factors for cancer development in this location |
| Q35206019 | As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia |
| Q34389716 | CT colonography: Friend or foe of practicing endoscopists |
| Q34275436 | Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance? |
| Q37696692 | Challenges and possible solutions to colorectal cancer screening for the underserved |
| Q37096832 | Challenges in the management of positive fecal occult blood tests |
| Q33812189 | Change in renal function after sodium phosphate preparation for screening colonoscopy |
| Q80426464 | Colorectal cancer screening program: cost effectiveness of systematic recall letters |
| Q37763182 | Colorectal cancer: current care, future innovations and economic considerations |
| Q46136488 | Colorectal testing utilization and payments in a large cohort of commercially insured US adults |
| Q34138849 | Community contextual predictors of endoscopic colorectal cancer screening in the USA: spatial multilevel regression analysis |
| Q51201268 | Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. |
| Q35074556 | Computer disease simulation models: integrating evidence for health policy |
| Q89108946 | Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare |
| Q38095383 | Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature |
| Q35173359 | Cost-Effectiveness of Colorectal Cancer Screening in High-Risk Spanish Patients: Use of a Validated Model to Inform Public Policy |
| Q35633134 | Cost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA. |
| Q36021151 | Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals. |
| Q30585018 | Dynamic tumor growth patterns in a novel murine model of colorectal cancer |
| Q35703309 | Early detection of colon cancer-the kaiser permanente northwest 30-year history: how do we measure success? Is it the test, the number of tests, the stage, or the percentage of screen-detected patients? |
| Q35528866 | Efficacy and cost-effectiveness of screening colonoscopy according to the adenoma detection rate |
| Q38161843 | FIT testing: an overview |
| Q33687986 | Findings on serial surveillance colonoscopy in patients with low-risk polyps on initial colonoscopy |
| Q84617669 | How can the over-use of surveillance colonoscopy after polypectomy be modified? |
| Q40605681 | How many individuals will need to be screened to increase colorectal cancer screening prevalence to 80% by 2018? |
| Q53458600 | Impact of a CT colonography screening program on endoscopic colonoscopy in clinical practice. |
| Q51165625 | Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province. |
| Q35980669 | Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations |
| Q36172866 | Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer. |
| Q33579388 | Mass spectrometry MALDI imaging of colon cancer biomarkers: a new diagnostic paradigm |
| Q38824739 | Most Premature Surveillance Colonoscopy Is Not Attributable to Bowel Preparation or New Clinical Indications |
| Q34129065 | Non-physician performance of lower and upper endoscopy: a systematic review and meta-analysis |
| Q30582557 | Optical colonoscopy and virtual colonoscopy numbers after initiation of a CT colonography program: long term data. |
| Q41699752 | Optimizing Patient Risk Stratification for Colonoscopy Screening and Surveillance of Colorectal Cancer: The Role for Linked Data |
| Q50895389 | Patient time requirements for screening colonoscopy. |
| Q38948810 | Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost? |
| Q34177292 | Postcolonoscopy Followup Recommendations: Comparison with and without Use of Polyp Pathology |
| Q34760177 | Predicting the risk of recurrent adenoma and incident colorectal cancer based on findings of the baseline colonoscopy |
| Q40674632 | Prediction of the Risk of a Metachronous Advanced Colorectal Neoplasm Using a Novel Scoring System. |
| Q33257469 | Predictors of colorectal cancer screening in diverse primary care practices |
| Q33716060 | Predictors of endoscopic colorectal cancer screening over time in 11 states |
| Q30487713 | Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018 |
| Q33879449 | Rate and yield of repeat upper endoscopy in patients with dyspepsia |
| Q38825618 | Risk of Advanced Neoplasia Using the National Cancer Institute's Colorectal Cancer Risk Assessment Tool. |
| Q36172692 | Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies |
| Q36039910 | Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses |
| Q36623391 | Screening tests for colorectal cancer: a menu of options remains relevant |
| Q38783500 | Sedation in the Endoscopy Suite |
| Q37221791 | Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis |
| Q41341883 | The Diagnostic Yield of Colonoscopy Stratified by Indications. |
| Q91747990 | The case for philanthropic investment to increase colorectal cancer screening rates: A novel paradigm to address a public health challenge |
| Q33618261 | Utilization of surveillance colonoscopy in community practice. |
| Q59283393 | Vacuna contra el virus del papiloma humano: razones para el optimismo y razones para la prudencia |
| Q37250373 | What is the most cost-effective strategy to screen for second primary colorectal cancers in male cancer survivors in Korea? |
| Q38192078 | miRNA as markers for the diagnostic screening of colon cancer |
Search more.